Uttarakhand Government issues notice to Patanjali over Coronil


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Uttarakhand Government issues notice to Patanjali over Coronil
Patanjali applied for Coronil as an immunity booster for cough and cold says Y S Rawat, Licensing officer

The Uttarakhand government is serving a notice to yoga guru Ramdev’s Patanjali Ayurved for launching a drug claiming to be a cure for coronavirus when it had only applied for a license to manufacture an immunity booster against cough and fever, an official said Wednesday.

The revelation from the state comes even as the AYUSH ministry at the Centre prepares to examine the herbal products company’s documents on research and the composition of the drug developed by it. Union minister Shripad Naik said Patanjali coming with the medicine was a "good initiative" but due process has to be followed. Hours after the launch of 'Coronil' on Tuesday, the Union AYUSH Ministry had asked the firm to provide the details, telling it to stop advertising it till the issue is examined. Naik said Patanjali Ayurved has submitted the documents.

"The reports which were sent to the ministry on Tuesday will be examined," he said.

"At a time when everybody is grappling for a cure for coronavirus, such an initiative is definitely good but then the due process has to be followed," the minister said.Apart from the notice from the Uttarakhand government, the Haridwar-based firm could also face litigation in Bihar. A complaint has been filed against it in a Muzaffarpur court over its claim.

Uttarakhand’s Ayurved department’s license officer YS Rawat said the notice is being issued to the firm to explain from where it got the permission to launch a "corona kit" as a cure for the virus.

"Patanjali Ayurved Ltd had the license only for manufacturing an immunity booster against cough and fever. There was nothing in their application related to the treatment of coronavirus," the official said.

"We did receive an application from Patanjali on June 10. The application was approved after examination by a panel on June 12 but the firm had the permission to manufacture only two or three drugs as immunity boosters against cough and fever, and not a drug for coronavirus," he added.

He said the notice will be sent to the firm under Rule 170 of the Drugs and Cosmetics Act, 1940, which makes it mandatory for companies to seek permission from the licensing authority before advertising a product in print or electronic media.

In Muzaffarpur, a complainant has approached the court seeking the registration of an FIR against Ramdev and company chairman Acharya Balkrishna, alleging that they put at risk the lives of lakhs of people by claiming to have developed a Covid-19 cure.

Chief Judicial Magistrate Mukesh Kumar posted the matter for hearing on June 30.

At the “Coronil” launch, the company had claimed that its medicine can cure the contagious disease within seven days.

It said “Coronil”, taken along with another product developed by it, had shown a 100% success rate in clinical trials on infected patients, except those on life support.

Ramdev said the medicines were developed by Patanjali Research Center, Haridwar in association with privately-owned National Institute of Medical Science, Jaipur.

Patanjali, however, is not the only herbal products company to have claimed coming up with a cure against the contagious disease.

The Advertising Standards Council of India (ASCI) has said it has found 50 campaigns by Ayurveda and homeopathic drug makers offering a cure for coronavirus in April alone and had flagged them to the Union government for action.

The advertisements violated the Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) order dated April 1, prohibiting publicity and advertisement of Ayush-related claims, an ASCI statement said.

The self-regulatory body said the ministry had sought its help to alert it about such advertisements.

The body also made public the list of the 50 companies which were found to have advertised a COVID-19 cure or a product to prevent it.

There were no big brands in the list, and most of them seemed to be localized entities from various parts of the country.

( Source PTI )

Tags : #Patanjali #Ramdev #Coronil #AyushMinistry #ShripadNaik #Coronakit #UttarakhandGovernment

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026
Dhiya Fertility and Maternity Center Performs Tamil Nadu’s First Robot-Assisted Fertility Procedure; 37-Year-Old Woman Delivers Healthy Baby GirlOctober 01, 2026
Habuild’s “Are You Still Awake?” Campaign Encourages India to Switch Off, Sleep on Time and Not Take Everything to Heart October 01, 2026
CoinSwitch Turns Profitable in FY26 as Revenue Surges 150% to ₹324 CrOctober 01, 2026
Mega CPR Training: Baby Memorial Hospital Vadakara enters Asia and India Book of RecordsOctober 01, 2026
Supertails vaccinates 300 dogs and cats against rabies across Bengaluru in a three-day World Rabies Day drive October 01, 2026
Why Continuity of Care Matters When Patients Move Between Health FacilitiesOctober 01, 2026
Building Stronger Referral Pathways Between Primary Care and Specialist ServicesOctober 01, 2026
How Can Diabetes and High Blood Pressure Quietly Lead to Kidney Failure?September 30, 2026
Apollo Hospitals’ “My Hands Are Ready” Sets World Record Title with 61,221 CPR Pledges in 30 DaysSeptember 30, 2026
How Medical Device Trials and Validation Shape Safer Healthcare Innovation in IndiaSeptember 30, 2026
Medical Device Safety in India: What Patients Should Know About Recalls and AlertsSeptember 30, 2026
Smart Implants: How Connected Devices Could Transform Follow-Up Care in IndiaSeptember 30, 2026
Single-Use Medical Devices: Innovation, Cost and Sustainability in Indian HealthcareSeptember 30, 2026
11th National Convention on Medicine & Law 2026 Successfully Concludes at D Y Patil University, Navi MumbaiSeptember 29, 2026
Can Your Skin Show the Signs of Chronic Stress? Dermatologists Explain What to Watch ForSeptember 29, 2026
MDI Gurgaon’s Samvaad X ScaNxt NXT STEP to Put Strategic Decision-Making Under Polycrisis Conditions to TestSeptember 29, 2026
Point-of-Care Diagnostics in India: Bringing Faster Testing Closer to PatientsSeptember 29, 2026
Adult Vaccination in India: The Preventive Care Gap Beyond ChildhoodSeptember 29, 2026
Maternal Nutrition Beyond Iron and Folic Acid: What Modern Prenatal Care in India Should IncludeSeptember 29, 2026